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Objective: This study aimed to assess the prevalence and predictors of non-adherence to
antihypertensive medication among patients with hypertension attending various healthcare
settings in Islamabad, Pakistan.
Methods: A questionnaire-based cross-sectional study was conducted in selected healthcare
facilities between September 2017 and December 2018. The study was conducted in primary,
secondary and tertiary healthcare settings in Islamabad, Pakistan. Medication adherence
was assessed using the eight-item Morisky Medication Adherence Scale (MMAS-8).
Sociodemographic and clinical data of recruited patients were collected through a structured
questionnaire. Binary logistic regression analysis was performed to determine covariates signiﬁ-
cantly associated with medication adherence and blood pressure control.
Results: A total of 776 hypertensive patients were invited and 741 (95%) completed the
questionnaire. The mean ± SD age of participants was 53.6±12.6 years; 284 patients (38.3%)
had high adherence, 178 (24%) hadmoderate adherence and 279 (37.7%) were non-adherent to the
prescribed antihypertensive therapy. Binary regression analysis revealed that old age (OR 1.783
[95% CI: 1.172–2.712]; P=0.013), being educated (OR 2.018 [95% CI: 1.240–3.284]; P=0.036),
entitlement to free medical care (OR 1.369 [95% CI: 1.009–1.859]; P=0.044), treatment duration
(OR 2.868 [95% CI: 1.913–4.299]; P=0.001), number of medications (OR 1.973 [95% CI:
1.560–2.495]; P=0.001), presence of any comorbidity (OR 2.658 [95% CI: 1.836–3.848];
P=0.001) and blood pressure control (OR 3.103 [95% CI: 2.268–4.247]; P=0.001) were signiﬁ-
cantly associated with good adherence. Similarly, age (OR 1.998 [95% CI: 1.313–3.040];
P=0.004), entitlement to free medical care (OR 1.498 [95% CI: 1.116–2.010]; P=0.007), treatment
duration (OR 1.886 [95% CI: 1.143–3.113]; P=0.013), presence of any comorbidity (OR 1.552
[95% CI: 1.123–2.147]; P=0.008) and adherence level (OR 3.103 [95% CI: 2.268–4.247];
P=0.001) had signiﬁcant association with controlled blood pressure. The following were the
main reasons for non-adherence to prescribed antihypertensive medication: “don’t feel need for
regular use“ (24.7%), “Carelessness“ (13.4%) and “adverse effects“ (11.2%).
Conclusion: The prevalence of non-adherence to antihypertensive medications was high in
the study population and poor medication adherence could potentially explain poor blood
pressure control. Evidence-based targeted interventions on both medication adherence and
blood pressure control should be introduced and implemented for better treatment outcomes.
Keywords: cross-sectional study, adherence, hypertension, Asia, antihypertensives, blood
pressure control, Pakistan
Introduction
Hypertension is a signiﬁcant global health challenge and a leading cause of morbidity
and mortality. Persistently elevated blood pressure may lead to stroke, myocardial
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infarction, congestive heart failure, renal failure and
blindness.1,2 In 2010, 1.3 billion people in the world were
suffering from hypertension, with an annual increase rate of
2.5%.3 According to theWorld Health Organization (WHO)
report published in 2013, the global prevalence of hyperten-
sion was 40%.4 Annually, 9.4 million people die from either
hypertension or its related complications worldwide.4
Hypertension control is a signiﬁcant healthcare challenge
for both developing and developed countries. In Australia
and the USA, the control rate for hypertension was 24% and
35%, respectively, in 2014–15.5 Hypertension control was
even worse in Asia, with India and China having control
rates of 7.9%6 and 5.7%,7 respectively. A meta-analysis
published in 2018 in Pakistan revealed that the overall
pooled prevalence of hypertension in Pakistan was 26.3%
(25.93–26.75%); subgroup analysis revealed that the urban
prevalence of hypertension was higher at 26.6% (21.80–
31.42%) as compared to the rural prevalence at 21.1%
(10.18–31.87%). Similarly, the pooled prevalence was
24.9% (19.70–30.28%) in males and 24.7% (16.76–
32.76%) in females.8
Poor adherence is a critical barrier to treatment
success9–11 leading to worsening of disease, increased
hospitalization rate and longer hospital stays. The esti-
mated overall global prevalence of non-adherence to anti-
hypertensive therapy is around 30%.12 In the USA, 5% of
avoidable hospital admissions are due to poor medication
adherence,13 costing approximately $100 billion
annually14 in the form of both direct and indirect losses.
Optimal adherence to prescribed antihypertensive therapy
may result in substantial reductions in the incidence of myo-
cardial infarction (20–25%), heart failure (>50%) and stroke
(35–40%).15,16 Various barriers to antihypertensive medica-
tion adherence have been previously identiﬁed and reported in
the literature. These include cost of medication, lack of educa-
tion, forgetfulness, unavailability, too much medication, fear
of addiction and possible side effects, and dissatisfaction with
the therapy.17 Therefore, addressing these barriers is necessary
to improve medication adherence.
This study aims to evaluate and compare the degree of
medication adherence in hypertensive patients in primary,
secondary and tertiary healthcare settings in Islamabad.
Previously, three studies were conducted in different ter-
tiary care hospitals in Pakistan to evaluate adherence to
medication in hypertensive patients. Of these three studies,
two used unvalidated questionnaires to assess medication
adherence and had too small sample sizes to draw any
meaningful conclusions.18,19 The largest study of the three
was conducted in 2005 in the city of Karachi in a large
tertiary care private hospital, and consisted of 460 hyper-
tensive patients. The Morisky, Green, Levine Medication
Adherence Questionnaire20 was used to assess adherence.17
Hypertension is managed primarily in primary care. In
Pakistan, 85% of patients visit primary healthcare facilities
for treatment, whereas only 15% of patients visit tertiary
care hospitals.21,22 To date, no study has been conducted in
Pakistan to assess the degree of medication adherence
among hypertensive patients attending primary and second-
ary care. To ﬁll this research gap, this study was designed to
gather a better understanding of the prevalence of and
barriers to medication adherence across all three tiers (pri-
mary, secondary and tertiary) of Pakistan's healthcare sys-
tem. The results of this study could inform policy makers to
help develop policies with the aim of improving medication
adherence for hypertensive patients in Pakistan.
Materials and Methods
Ethics Statement
The study was approved by Quaid-i-Azam University
Bioethics Committee (vide letter no. BFC-FBS-QAU
-2018-108 dated 23/10/2018.) In addition, ethical approval
was obtained from the bioethical committees/administra-
tions of the respective healthcare settings where the study
was conducted (vide letter no. F.1-1/2015/ERB/SZABMU
dated 28/08/2017 and no. CDA/DHS-14(1) (63)/2018/1077
dated: 09/10/2018). A licensing agreement to use the copy-
righted MMAS-8 was obtained from Donald E. Morisky
(294 Lindura Court, Las Vegas, NV 89138-4632, USA;
dmorisky@gmail.com). Both informed and written consent
was sought from each participant using a consent form
before enrollment in the study. Survey conﬁdentiality and
anonymity were assured to all enrolled participants.
Study Settings
This was a multicentre study conducted in one primary, one
secondary and one tertiary healthcare setting in Islamabad,
the capital of Pakistan. This study was conducted in all three
tiers of Pakistan’s healthcare system to enable generaliza-
tion of the data to the Pakistani population.
Study Design and Participants
This was a cross-sectional study including 741 hypertensive
patients. The study took place between September 2017 and
December 2018. Eligibility criteria included: all patients
who were diagnosed with essential hypertension at any
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time; aged 18 years and above; on at least one antihyper-
tensive medication for the past 6 months; able to commu-
nicate in Urdu language; and attending one of the
participating healthcare facilities. Hypertensive patients
with other comorbidities were also included in our study.
Pregnant women, patients with mental disorders such as
dementia, and those who could not communicate in Urdu,
which is the national language of Pakistan, were not
included in this study.
Data Collection
To assess medication adherence, the Urdu version of the
eight-item Morisky Medication Adherence Scale (MMAS-
8) was used.23–25 Since Urdu is the national language and
is the most widely spoken and understood language in
Pakistan, a validated Urdu translation of MMAS-826 was
used to measure medication adherence. The MMAS-8
score can range between 0 and 8. Participants who scored
8 on MMAS-8 were considered “adherent”, participants
with a score between 6 and <8 were considered “moder-
ately adherent” and participants with an MMAS-8 score
<6 were considered “non-adherent” to their prescribed
therapy.25 A separate standardized data collection form
was used to gather patients' sociodemographic data, med-
ical and medication history, and reason for non-adherence.
The questionnaires were piloted on 50 patients to test the
acceptability of the questions.
Outcome Measures and Covariates
The primary and secondary outcome measures were opti-
mal medication adherence and optimal blood pressure
control, respectively. The target for controlled blood pres-
sure was deﬁned in accordance with NICE treatment
guidelines for the management of hypertension 2011.27
For patients who were under 80 years of age, blood pres-
sure <140/90 mmHg was considered controlled, whereas
for patients aged 80 years or above, blood pressure <150/
90 mmHg was considered controlled. Similarly, for the
patients with both hypertension and diabetes mellitus,
blood pressure <140/80 mmHg, and for patients with
kidney, eye and cerebrovascular damage, blood pressure
<130/80 mmHg was considered controlled. The covariates
were age, gender, entitlement status, marital status, level
of education, profession, smoking, number of antihyper-
tensive medications used, duration of therapy and presence
of comorbidities.
Statistical Analysis
Statistical analyses were performed using SPSS version
21.0. The alpha level of signiﬁcance for all statistical
tests was 0.05. Binary logistic regression analysis using
the default entry method was conducted to identify pre-
dictors associated with medication adherence and blood
pressure control. For the purposes of binary regression
analysis, the patients were divided into two categories, ie
either adherent or non-adherent, rather than three cate-
gories, ie good adherence, moderate adherence and non-
adherence, on the basis of their MMAS-8 score. Patients
who had an MMAS-8 score ≥6 were categorized as adher-
ent and patients who had an MMAS-8 score <6 were
categorized as non-adherent. Correlation and Hosmer–
Lemeshow Goodness of Fit tests were performed to select
the best prediction model.
Results
Patient Characteristics
A total of 768 hypertensive patients using at least one
antihypertensive medication were invited to participate,
of whom 741 patients participated in the study
(Figure 1). Of these 741 patients, 389 (52.5%) were male
and 352 (47.5%) were female. The mean age of partici-
pants was 53.6±12.6 years. More than one-third of the
participants (286, 38.6%) were obese. At least one comor-
bidity was present in 205 patients (27.7%) (Table 1). The
majority of participants were on a single antihypertensive
drug (303, 40.9%) and the mean number of antihyperten-
sive medications used was 1.7. The mean duration of
therapy was 5.7 years and the majority of participants
had a duration of therapy <5 years (498, 67.2%). The
mean MMAS-8 score was 6.17±1.8; 462 patients
(62.3%) scored >6 and adherence was categorized as
either good or moderate, whereas 279 patients (37.6%)
scored <6 and were categorized as poor adherents. The
Participants Invited for Study
(776)
Participants From Tertiary 
care Hospital
(387)
Participants From 
Secondary care Hospital
(203)
Participants From Primary 
care Centre
(151)
Incomplete Questionnaires 
Excluded
(35)
Figure 1 Flowchart showing the participants from each healthcare setting.
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Table 1 Characteristics of Patients Included in This Study
Patient Characteristics Total Study Population (N=741)
N %
Gender Male 389 52.5
Female 352 47.5
Age Mean ± SD 53.6±12.6
≥60 years 256 34.5.
40–59 years 343 46.3
≤40 years 142 19.2
Marital status Married 632 85.3
Unmarried/divorced/widowed 109 14.7
BMI Overweight 286 38.6
Normal 411 55.5
Underweight 44 5.9
Smoking Non-smokers 585 78.9
Smokers 104 14
Ex-smokers 52 7
Educational level Graduate and above 122 16.5
Secondary and higher secondary 262 35.4
Primary and below 163 22
Uneducated 194 26.2
Profession Ofﬁcers/higher management 78 10.5
Clerical staff 62 8.4
Workers/labourers 148 20
Self-employed 15 2
Retired/unemployed 140 18.9
Housewives 298 40.2
Entitlement status Entitled 303 40.9
Non-entitled 438 59.1
Treatment duration Mean ± SD 5.7±5.9
≤5 years 498 67.2
6–9 years 73 9.9
≥10 years 170 22.9
No. of antihypertensive drugs Mean ± SD 1.7±0.68
1 303 40.9
2 340 45.9
3 97 13.1
4 1 0.1
Comorbidity Yes 536 72.3
No 205 27.7
Speciﬁc comorbidity Patients with DM 125 16.9
Patients with CHD 63 8.50
Patients with CHF 06 0.80
Patients with hyperlipidaemia 169 22.8
Blood pressure Controlled 357 48.2
Uncontrolled 384 51.8
Abbreviations: BMI, body mass index; DM, diabetes mellitus; CHD, coronary heart disease; CHF, congestive heart failure.
Mahmood et al Dovepress
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mean systolic blood pressure was 148±18.6 mmHg
and mean diastolic blood pressure was 92±10.7 mmHg.
The mean systolic blood pressure was 145±19 mmHg in
patients with good medication adherence, 148±18 mmHg
in patients with moderate adherence and 152±18 mmHg in
patients with low medication adherence. Similarly, the
mean diastolic blood pressure was 90±11 mmHg in
patients with good medication adherence, 92±11 mmHg
in patients with moderate adherence and 95±10 mmHg in
patients with low medication adherence (Table 2).
Factors Associated with Medication
Adherence
Patients were categorized into adherent, moderately adher-
ent and non-adherent on the basis of their MMAS-8 score.
In terms of level of care, univariate analysis found that
patients attending the tertiary care hospital had a higher
rate of medication adherence (169/387, 43.6%) compared
to secondary care (79/203, 38.90%) and the primary care
centre (36/151, 23.8%) (Table 3).
Table 4 shows the results of binary regression analysis
for factors predicting medication adherence. Older age
(OR 1.783 [95% CI: 1.172–2.712]), being educated (OR
2.018 [95% CI: 1.240–3.284]) and longer treatment dura-
tion increased the odds of being adherent (OR 2.868 [95%
CI: 1.913–4.299]). Married patients were more likely to be
adherent to the antihypertensive therapy than unmarried/
divorced/widowed patients (OR 1.25 [95% CI:
0.827–1.890]). Patients who were entitled to free medical
care were more likely to be adherent to prescribed anti-
hypertensive therapy than patients who were non-entitled
(OR 1.369 [95% CI: 1.009–1.859]). The odds of being
adherent increased by 1.973 [95% CI: 1.560–2.495]
times with every unit increase in number of antihyperten-
sive medications. Similarly, patients who had comorbidity
were more likely to be adherent to the antihypertensive
therapy than the patients who had no comorbidity (OR
2.658 [95% CI: 1.836–3.848]). Patients with controlled
blood pressure were three times more likely to be adherent
than those with uncontrolled blood pressure (OR 3.103
[95% CI: 2.268–4.247]). Male patients were more likely
to be adherent than female patients (OR 1.134 [95% CI:
0.842–1.527]).
Factors Associated with Optimal Blood
Pressure Control
Univariate analysis revealed that the rate of blood pressure
control was 63.7% among patients who had high medica-
tion adherence, compared to 50% among patients with
moderate adherence and 31.2% among patients who had
low adherence to prescribed antihypertensive medication
(Table 5). The rate of blood pressure control was 44% in
patients attending the tertiary care hospital, 56% in patients
attending the secondary care hospital and 49% in patients
attending the primary healthcare setting. The overall rate of
blood pressure control was 48% (Table 6).
The results of binary regression analysis showed that age,
entitlement status for free medical care, treatment duration,
presence of any comorbidity and adherence level had signiﬁ-
cant associations with controlled blood pressure. The results of
binary regression analysis further revealed that the odds of
controlled blood pressure were approximately three times
greater in patients who were adherent to their prescribed
antihypertensive therapy than in patients who were non-
adherent (OR 3.103 [95% CI: 2.268–4.247]). Similarly, the
Table 2 Mean SBP and DBP Stratiﬁed by Adherence Level
Adherence Level Mean SBP
(mmHg)
Mean DBP
(mmHg)
Good adherence 145±19 90±11
Moderate adherence 148±18 92±11
Low adherence 152±18 95±10
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure.
Table 3 Medication Adherence Level in Different Healthcare Settings
Healthcare Setting No. of Patients, N Adherent, N (%) Moderate Adherence, N (%) Non-Adherence, N (%)
Tertiary care hospital 387 169 (43.66) 90 (23.26) 128 (33.07)
Secondary care hospital 203 79 (38.90) 47 (23.15) 77 (37.93)
Primary care centre 151 36 (23.8) 41 (27.15) 74 (49.0)
Overall 741 284 (38.3) 178 (24.0) 279 (37.7)
Notes: The level of adherence was measured through the eight-item Morisky Medication Adherence Scale (MMAS-8). Use of the MMAS is protected by US copyright laws.
Permission for use is required. A licensing agreement is available from: Donald E. Morisky, ScD, ScM, MSPH. Use of the ©MMAS is protected by US copyright and registered
trademark laws. Permission for use is required. A licensing agreement is available from: Donald E. Morisky, 294 Lindura Court, Las Vegas, NV 89138-4632; dmorisky@gmail.
com. The scale’s questions are available in the originally published article.23
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Table 4 Binary Logistic Regression Analysis for Factors Predicting Medication Adherence
Parameter Non-Adherent, N (%) Adherent, N (%) OR 95% CI for OR
Lower–Upper
P-value
Gender
Female 138 (39.2) 214 (60.8) 1
Male 141 (36.2) 248 (63.8) 1.134 0.842–1.527 0.407
Age
18–40 years 68 (48.6) 72 (51.4) 1
41–59 years 122 (35.5) 222 (64.5) 1.719 1.154–2.559
≥60 years 89 (34.6) 168 (65.4) 1.783 1.172–2.712 0.013*
Marital status
Married 233 (36.9) 399 (63.1) 1
Unmarried/divorced/widowed 46 (42.2) 63 (57.8) 0.800 0.529–1.209 0.289
Educational level
Uneducated 85 (43.8) 109 (56.2) 1
Primary or below 65 (39.9) 98 (60.1) 1.176 0.770–1.794
Secondary and higher secondary 95 (36.3) 167 (63.7) 1.371 0.938–2.003
Graduate and above 34 (27.9) 88 (72.1) 2.018 1.240–3.284 0.036*
BMI
Obese 109 (38.1) 177 (61.9) 1
Normal weight 157 (38.2) 254 (61.8) 0.996 0.730–1.359
Underweight 13 (29.5) 31 (70.5) 1.468 0.736–2.928 0.523
Profession
Retired/unemployed 53 (37.9) 87 (62.1) 1
Housewives 113 (37.9) 185 (62.1) 1.003 0.663–1.517
Ofﬁcers 23 (29.5) 55 (70.5) 1.461 0.851–2.507
Clerical staff 23 (37.1) 39 (62.9) 1.036 0.588–1.824
Worker/labourer 58 (39.2) 90 (60.8) 0.948 0.632–1.420
Self-employed 9 (60) 6 (40) 0.407 0.141–1.174 0.376
Entitlement status
Non-entitled 178 (40.6) 260 (59.4) 1
Entitled 101 (33.3) 202 (66.7) 1.369 1.009–1.859 0.044*
Smoking status
Non-smoker 222 (37.9) 363 (62.1) 1
Smoker 40 (38.5) 64 (61.5) 0.979 0.637–1.503
Ex-smoker 17 (32.7) 35 (67.3) 1.259 0.689–2.301 0.743
Treatment duration
≤5 years 221 (44.4) 277 (55.6) 1
6–9 years 21 (28.8) 52 (71.2) 1.976 1.155–3.379
≥10 years 37 (21.8) 133 (78.2) 2.868 1.913–4.299 0.0001*
No. of medications
1 151 (49.8) 152 (50.2)
2 107 (31.5) 233 (68.5)
3 20 (20.6) 77 (79.4) 1.973 1.560–2.495 0.0001*
Comorbidities
No 233 (43.5) 303 (56.5) 1
Yes 46 (22.4) 159 (77.6) 2.658 1.836–3.848 0.0001*
(Continued)
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odds of controlled blood pressure were 1.179 times greater in
males than in females (OR 1.179 [95% CI: 0.883–1.574]).
Older age (≥60 years) (OR 1.998 [95% CI: 1.313–3.040]),
being educated (OR 1.5 [95% CI: 0.956–2.377]), being an
ofﬁcer (OR 1.5 [95% CI: 0.923–2.516]) and longer treatment
duration (OR 1.4 [95% CI: 1.010–2.031]) increased the odds
of controlled blood pressure. The odds of controlled blood
pressure were 1.213 times greater in unmarried/divorced/
widowed patients than in married patients (OR 1.213 [95%
CI: 0.807–1.822]). The odds of controlled blood pressure were
1.5 times greater in patients who had entitlement to free
medical care than in who did not have entitlement to free
medical care (OR 1.498 [95% CI: 1.116–2.010]). The number
of medications had an inverse relationship with controlled
blood pressure with every unit increase in number of medica-
tions (OR 0.884 [95% CI: 0.716–1.091]). The odds of con-
trolled blood pressure were 1.5 times greater in patients who
had comorbidity than in patients who had no comorbidity (OR
1.552 [95% CI: 1.123–2.147]) (Table 7).
Reasons for Non-Adherence/Moderate
Adherence
Multiple reasons for moderate/non-adherence were
reported by the patients. Of 457 hypertensive patients,
408 (89%) who had either moderate adherence or non-
adherence responded to the question on the reasons for
non-adherence. About one-quarter of the patients (24.7%)
responded that they “don’t feel a need for regular use” as
they take their medicines only when they feel any symp-
tom of hypertension. Carelessness was the second most
frequently cited reason for moderate/non-adherence
(13.4%). Adverse effects to antihypertensive medications
were also cited by 46 patients (11.2%) (Table 8).
Table 6 Level of Blood Pressure Control in Different Healthcare Settings
Healthcare Setting Total No. of Patients BP Controlled BP, N (%) % Uncontrolled BP, N (%) %
Tertiary care hospital 387 169 (44) 44 218 (56) 56
Secondary care hospital 203 113 (56) 56 90 (44) 44
Primary care centre 151 74 (49) 49 77 (51) 51
Overall 741 356 (48) 48 385 (52) 52
Abbreviation: BP, blood pressure.
Table 4 (Continued).
Parameter Non-Adherent, N (%) Adherent, N (%) OR 95% CI for OR
Lower–Upper
P-value
BP control
Uncontrolled 192 (50.0) 192 (50.0) 1
Controlled 87 (24.4) 270 (75.6) 3.103 2.268–4.247 0.0001*
Note: *P<0.05.
Abbreviations: BMI, body mass index; BP, blood pressure.
Table 5 Adherence Level Among Hypertensive Patients Stratiﬁed by Blood Pressure Control
Adherence Level Blood Pressure Total Study Population
N % Total (%)
High adherence Controlled 181 63.7 284 (38.3)
Uncontrolled 103 36.3
Moderate adherence Controlled 89 50 178 (24)
Uncontrolled 89 50
Low adherence Controlled 87 31.2 279 (37.7)
Uncontrolled 192 68.8
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Table 7 Binary Logistic Regression Analysis for Factors Predicting Controlled Blood Pressure
Parameter Uncontrolled BP, N (%) Controlled BP, N (%) OR 95% CI for OR Lower-Upper P-value
Gender
Female 190 (54.0) 162 (46.0) 1
Male 194 (49.9) 195 (50.1) 1.179 0.883–1.574 0.264
Age
18–40 years 86 (61.4) 54 (38.6) 1
41–59 years 184 (53.5) 160 (46.6) 1.385 0.927–2.068
≥60 years 114 (44.4) 143 (55.6) 1.998 1.313–3.040 0.004*
Marital status
Married 332 (52.5) 300 (47.5) 1
Unmarried/divorced/widowed 52 (47.7) 57 (52.3) 1.213 0.807–1.822 0.352
Education
Uneducated 112 (57.7) 82 (42.3) 1
Primary or below 79 (48.5) 84 (51.5) 1.452 0.955–2.208
Secondary and higher
secondary
135 (51.5) 127 (48.5) 1.285 0.884–1.868
Graduate and above 58 (47.5) 64 (52.5) 1.507 0.956–2.377 0.227
BMI
Obese 152 (53.1) 134 (46.9) 1
Normal weight 216 (52.6) 195 (47.4) 1.024 0.757–1.386
Underweight 16 (36.4) 28 (63.6) 1.985 1.029–3.828 0.113
Profession
Housewives 165 (55.4) 133 (44.6) 1
Ofﬁcers 35 (44.9) 43 (55.1) 1.524 0.923–2.516
Clerical staff 33 (53.2) 29 (46.8) 1.090 0.630–1.887
Worker/labourer 77 (52.0) 71 (48.0) 1.144 0.771–1.698
Retired/unemployed 65 (46.4) 75 (53.6) 1.431 0.957–2.142
Self-employed 9 (60.0) 6 (40.0) 0.827 0.287–2.382 0.407
Entitlement status
Non-entitled 245 (55.9) 193 (44.1) 1
Entitled 139 (45.9) 164 (54.1) 1.498 1.116–2.010 0.007*
Smoking status
Non-smoker 301 (51.5) 284 (48.5) 1
Smoker 58 (55.8) 46 (44.2) 0.841 0.553–1.279
Ex-smoker 25 (48.1) 27 (51.9) 1.145 0.649–2.019 0.615
Treatment duration
≤5 years 276 (55.4) 222 (44.6) 1
6–9 years 29 (39.7) 44 (60.3) 1.886 1.143–3.113
≥10 years 79 (46.5) 91 (53.5) 1.432 1.010–2.031 0.013*
No. of medications
1 156 (51.5) 147 (48.5)
2 168 (49.4) 172 (50.6)
3 59 (60.8) 38 (39.2) 0.884 0.716–1.091 0.250
Comorbidities
No 294 (54.9) 242 (45.1) 1
Yes 90 (43.9) 115 (56.1) 1.552 1.123–2.147 0.008*
(Continued)
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Discussion
Medication adherence, predictors of medication adherence
and its association with controlled blood pressure, as well as
the reasons for medication non-adherence, were investigated
in this study. Patient groups with poor blood pressure control
were identiﬁed. This study could potentially help medical
practitioners to design patient-speciﬁc interventions targeting
these patients, including patient counselling, providing entitle-
ment to free medical care and helping policy makers develop
policies to ensure better therapeutic outcomes. Overall, 37.7%
of hypertensive patients attending primary, secondary and
tertiary healthcare settings in Islamabad were non-adherent.
There was a signiﬁcant association betweenmedication adher-
ence and blood pressure control. “Don’t feel need for regular
use”, “Carelessness” and “adverse effects” were the main
reasons for non-adherence among hypertensive patients.
Previous studies conducted in Pakistan have reported
higher rates of non-adherence to antihypertensive therapy,
ranging between 51% and 82%18,19, compared to our study.
This difference may be due to the use of unvalidated ques-
tionnaires to assess medication adherence and very small
sample sizes (89 and 32). The use of unvalidated question-
naires may have resulted in overestimation of non-
adherence. However, one study, conducted in the
metropolitan city of Karachi, Pakistan,17 was the only
research study that used a validated questionnaire, ie the
Morisky, Green, Levine Medication Adherence
Questionnaire. Our study reported less medication adher-
ence than was reported in the previous study conducted in
Karachi, ie 77%. This difference may be due to the different
methods used to estimate adherence, as it has been reported
in a meta-analysis that MMAS-8 reports less adherence
compared to other questionnaires used for the estimation
of medication adherence. This is because MMAS-8 makes
it possible to obtain a more in-depth picture of adherence,
where the participants do not feel forced to claim to be
adherent.28 Various studies conducted in different Asian
countries, ie China, Hong Kong, Saudi Arabia, UAE and
Iran, using MMAS-8 have also reported similar poor adher-
ence to prescribed antihypertensive therapy, supporting our
results.15,29–35
The WHO estimates the prevalence of non-adherence
among patients with chronic diseases to be between 52%
and 74%, deﬁned by ≥80% cut-off.36
In this study, we found no signiﬁcant correlation between
gender and medication adherence. This ﬁnding is consistent
with previously reported studies, including a study in
Pakistan.17,30,31,37,38 In contrast, there are studies that have
found a signiﬁcant correlation between gender and medica-
tion adherence.29,32 Age was found to be signiﬁcantly asso-
ciated with medication adherence in our study, with better
adherence observed in older patients. This ﬁnding is consis-
tent with another study from Pakistan,17 as well as with
a number of international studies.29,39–42 However, other
studies have shown either no correlation with age43,44 or
an inverse correlation with increasing age when it comes to
the use of antihypertensives.45
In our opinion, this negative correlation may be due to
loss of memory, non-availability of any caregiver or dete-
riorated health of the patients. On the other hand, the
increased medication adherence in older patients may be
due to either increased severity of the condition, which
forced the patient to be adherent, or strong family support
Table 7 (Continued).
Parameter Uncontrolled BP, N (%) Controlled BP, N (%) OR 95% CI for OR Lower-Upper P-value
Medication adherence level
Non-adherent 192 (68.8) 87 (31.2) 1
Adherent 192 (41.6) 270 (58.4 3.103 2.268–4.247 0.0001*
Note: *P<0.05.
Abbreviations: BMI, body mass index; BP, blood pressure.
Table 8 Reasons “In Patient’s View” for Either Non-Adherence
or Moderate Adherence to Prescribed Antihypertensive Therapy
Sr. Reason n (%)
No. of Respondents (n=408)
1 Don't feel need for regular use 101 (24.7)
2 Carelessness 55 (13.4)
3 Adverse effect 46 (11.2)
4 Forgetfulness 40 (9.8)
5 Lack of education 40 (9.8)
6 Travelling 35 (8.6)
7 Tired of taking medication 31 (7.6)
8 Fear of addiction 24 (5.9)
9 Unaffordable 19 (4.7)
10 Unavailability 16 (3.9)
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for older people in Pakistani society. Studies have reported
a positive relationship between family support and medi-
cation adherence.46,47
The level of education of the participants was also found
to be signiﬁcantly associated with medication adherence in
our study. There was a positive correlation between medi-
cation adherence and the level of education. This is in
contrast to what has been reported previously in studies
conducted in different Asian countries, as most of the pre-
vious studies using MMAS-8 have found no signiﬁcant
correlation between level of education and medication
adherence.17,29–31,37 Increased medication adherence in
educated patients may be due to increased awareness
about the disease. This is in line with previous research
which showed the signiﬁcant relationship between formal
education and medication adherence.48,49
The number of medications had a signiﬁcant correla-
tion with medication adherence. Medication adherence
increases when the patient is using more than one medica-
tion to control blood pressure. This ﬁnding is in contrast to
previously reported studies, which found no signiﬁcant
correlation between number of medications and
medicationadherence.17,29–31,37,38 In our opinion, the
increased medication adherence in patients who use more
than one medication to control their blood pressure may be
due to an increased severity of symptoms in these patients,
which compels these patients to remain adherent with their
prescribed medications.
Similarly, presence of comorbidity also had strong
a correlation with medication adherence. Mixed ﬁndings
have been reported in the literature regarding the associa-
tion between presence of comorbidity and medication
adherence. Some studies support our ﬁnding,29,38 whereas
other studies found no signiﬁcant correlation between pre-
sence of comorbidity and medication adherence.17,31,37 No
signiﬁcant correlation was found between gender, marital
status, BMI, smoking or employment status and medica-
tion adherence.
For blood pressure control, the age of the patient was
found to have a signiﬁcant correlation with controlled
blood pressure. We found that patients aged ≥60 years
had better blood pressure control than patients who were
under 60 years of age. This ﬁnding is in contrast to pre-
viously reported studies, which found the opposite
result.29,50 This better control of blood pressure could be
due to better medication adherence in elderly patients and
increased self-care in old age.
This study also highlighted various self-reported rea-
sons for medication non-adherence/moderate adherence
among Pakistani patients. These reasons included “no
need for regular use”, carelessness, adverse effects of
medication, forgetfulness, lack of education, travelling,
tired of taking medicines, fear of addiction, unaffordability
and unavailability. A previous study, also conducted in
Pakistan, reported misperception, no need for medications,
ineffectiveness, forgetfulness, unavailability and adverse
effects of medications as the main reasons for non-
adherence in hypertensive patients.19 A study conducted
in India revealed that forgetfulness, blood pressure
assumed to be normal and non-availability were the main
reasons for non-adherence.51 Similarly, a study conducted
in Bangladesh reported that forgetfulness, feeling well/no
need for medication use and busy schedule were the three
main reasons for non-adherence.52 In another study con-
ducted in Bangladesh, forgetfulness, busy schedule and
boredom were reported as the three main factors for med-
ication non-adherence in hypertensive patients.53 All of
these South Asian studies showed that forgetfulness, feel-
ing well/no need for medicines were the major reasons for
medication non-adherence in hypertensive patients.
Implications for Clinical Practice
The ﬁndings of this study have critical implications for
healthcare practitioners and policy makers. There is a clear
need to design and implement different interventions with
the aim of improving medication adherence among
patients. In this study, we have identiﬁed different predic-
tors for medication adherence, such as age, level of educa-
tion, entitlement/insurance status, treatment duration,
number of antihypertensive medications and presence of
comorbidities. Hence, any intervention targeting any of
these predictors could be helpful in improving medication
adherence. Effective strategies to improve medication
adherence can be achieved through better communications
between the physician and patient and can help to improve
medication adherence. Interventions have to be patient
speciﬁc in order to be successful. Patient-related factors
such as gender, culture, health beliefs and knowledge
about disease should be kept in mind when designing
any intervention for improving medication adherence.
Limited local evidence is available on the effectiveness
of interventions to improve medication adherence among
hypertensive patients in Pakistan. However, internation-
ally, effective interventions to improve medication adher-
ence include educational programmes involving both
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patients and family members, in the form of individual
instructions or group classes; regular monitoring of blood
pressure at home; providing entitlement to free medical
care; simplifying the dosing regimen; and behavioural
interventions, such as memory aids and synchronizing
therapeutic activities with the daily routine, eg taking
medications before a shower or after prayer.54,55 The exist-
ing literature has demonstrated that interventions aimed at
improving health literacy, using communication technolo-
gies such as mobile applications and sending SMS remin-
ders, electronic medication reconciliation and motivational
interviewing can improve medication adherence and may
have positive effects on treatment outcomes.56–63
Study Limitations
There are a few limitations to our study ﬁndings. This study
was conducted in only one city in Pakistan; therefore, the
ﬁndings may not be generalizable to other cities, towns and
villages. Self-administered questionnaires were used in this
research to assess medication adherence, which may lead to
under- or overestimation of results. This questionnaire
required recall of previous events, which may lead to recall
bias, especially in older patients or those who had been on
antihypertensive treatment for many years. However,
MMAS-8 has very well-documented reliability and validity
in assessing medication adherence. In this study, comorbid-
ity was recorded as a dichotomous outcome (present/not
present); however, the number and nature of comorbidities,
which could potentially affect medication adherence and
treatment outcome, were not recorded. Future studies
should collect data focusing on the number and nature of
comorbidities, and their impact on medication adherence.
Conclusion
Adherence to prescribed antihypertensive medications was
suboptimal in hypertensive patients attending different
healthcare settings in Islamabad, Pakistan. This suboptimal
medication adherence was associated with poor blood
pressure control. Keeping in view the predictors of good
blood pressure control identiﬁed in this study, targeted
interventions should be introduced and implemented for
better treatment outcomes.
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